Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Dec;57(12):1071–1078. doi: 10.1136/thorax.57.12.1071

Lung cancer • 2: Screening and early diagnosis of lung cancer

J Mulshine 1, R Smith 1
PMCID: PMC1758795  PMID: 12454304

Full Text

The Full Text of this article is available as a PDF (159.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailar J. C., 3rd Screening for lung cancer--where are we now? Am Rev Respir Dis. 1984 Oct;130(4):541–542. doi: 10.1164/arrd.1984.130.4.541. [DOI] [PubMed] [Google Scholar]
  2. Beam C. A., Layde P. M., Sullivan D. C. Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample. Arch Intern Med. 1996 Jan 22;156(2):209–213. [PubMed] [Google Scholar]
  3. Cady B. Breast cancer in the third millennium. J Surg Oncol. 2001 Aug;77(4):225–232. doi: 10.1002/jso.1100. [DOI] [PubMed] [Google Scholar]
  4. Cady B., Michaelson J. S. The life-sparing potential of mammographic screening. Cancer. 2001 May 1;91(9):1699–1703. doi: 10.1002/1097-0142(20010501)91:9<1699::aid-cncr1186>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  5. Carney Desmond N. Lung cancer--time to move on from chemotherapy. N Engl J Med. 2002 Jan 10;346(2):126–128. doi: 10.1056/NEJM200201103460211. [DOI] [PubMed] [Google Scholar]
  6. Chute J. P., Chen T., Feigal E., Simon R., Johnson B. E. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol. 1999 Jun;17(6):1794–1801. doi: 10.1200/JCO.1999.17.6.1794. [DOI] [PubMed] [Google Scholar]
  7. Dahl A. R., Grossi I. M., Houchens D. P., Scovell L. J., Placke M. E., Imondi A. R., Stoner G. D., De Luca L. M., Wang D., Mulshine J. L. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res. 2000 Aug;6(8):3015–3024. [PubMed] [Google Scholar]
  8. Duffy S. W., Tabar L. Screening mammography re-evaluated. Lancet. 2000 Feb 26;355(9205):747–752. doi: 10.1016/S0140-6736(05)72152-8. [DOI] [PubMed] [Google Scholar]
  9. Field J. K., Brambilla C., Caporaso N., Flahault A., Henschke C., Herman J., Hirsch F., Lachmann P., Lam S., Maier S. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol. 2002 Aug;21(2):369–373. doi: 10.3892/ijo.21.2.369. [DOI] [PubMed] [Google Scholar]
  10. Gaeta M., Volta S., Barone M., Caruso R., Loria G., Pandolfo I., Minutoli A. Carcinoma bronchioloalveolare. Quadri con tomografia computerizzata e correlazioni istologiche. Radiol Med. 1994 Apr;87(4):427–434. [PubMed] [Google Scholar]
  11. Ginsberg R. J., Rubinstein L. V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995 Sep;60(3):615–623. doi: 10.1016/0003-4975(95)00537-u. [DOI] [PubMed] [Google Scholar]
  12. Henschke C. I., McCauley D. I., Yankelevitz D. F., Naidich D. P., McGuinness G., Miettinen O. S., Libby D. M., Pasmantier M. W., Koizumi J., Altorki N. K. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999 Jul 10;354(9173):99–105. doi: 10.1016/S0140-6736(99)06093-6. [DOI] [PubMed] [Google Scholar]
  13. Henschke C. I., Naidich D. P., Yankelevitz D. F., McGuinness G., McCauley D. I., Smith J. P., Libby D., Pasmantier M., Vazquez M., Koizumi J. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001 Jul 1;92(1):153–159. doi: 10.1002/1097-0142(20010701)92:1<153::aid-cncr1303>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  14. Hirsch F. R., Franklin W. A., Gazdar A. F., Bunn P. A., Jr Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001 Jan;7(1):5–22. [PubMed] [Google Scholar]
  15. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. doi: 10.1056/NEJM199009203231205. [DOI] [PubMed] [Google Scholar]
  16. Jemal Ahmedin, Thomas Andrea, Murray Taylor, Thun Michael. Cancer statistics, 2002. CA Cancer J Clin. 2002 Jan-Feb;52(1):23–47. doi: 10.3322/canjclin.52.1.23. [DOI] [PubMed] [Google Scholar]
  17. Kaneko M., Kusumoto M., Kobayashi T., Moriyama N., Naruke T., Ohmatsu H., Kakinuma R., Eguchi K., Nishiyama H., Matsui E. Computed tomography screening for lung carcinoma in Japan. Cancer. 2000 Dec 1;89(11 Suppl):2485–2488. doi: 10.1002/1097-0142(20001201)89:11+<2485::aid-cncr28>3.3.co;2-k. [DOI] [PubMed] [Google Scholar]
  18. Kelloff G. J. Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res. 2000;78:199–334. doi: 10.1016/s0065-230x(08)61026-x. [DOI] [PubMed] [Google Scholar]
  19. King C., 3rd, Siegel M. The Master Settlement Agreement with the tobacco industry and cigarette advertising in magazines. N Engl J Med. 2001 Aug 16;345(7):504–511. doi: 10.1056/NEJMsa003149. [DOI] [PubMed] [Google Scholar]
  20. Kurie J. M., Lee J. S., Khuri F. R., Mao L., Morice R. C., Lee J. J., Walsh G. L., Broxson A., Lippman S. M., Ro J. Y. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res. 2000 Aug;6(8):2973–2979. [PubMed] [Google Scholar]
  21. Lippman S. M., Lee J. J., Karp D. D., Vokes E. E., Benner S. E., Goodman G. E., Khuri F. R., Marks R., Winn R. J., Fry W. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001 Apr 18;93(8):605–618. doi: 10.1093/jnci/93.8.605. [DOI] [PubMed] [Google Scholar]
  22. Marshall D., Simpson K. N., Earle C. C., Chu C. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer. 2001 Jun;32(3):227–236. doi: 10.1016/s0169-5002(00)00239-7. [DOI] [PubMed] [Google Scholar]
  23. McQuarrie H. G., Ogden J., Costa M. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears. J Reprod Med. 2000 Nov;45(11):898–906. [PubMed] [Google Scholar]
  24. Miettinen Olli S., Henschke Claudia I., Pasmantier Mark W., Smith James P., Libby Daniel M., Yankelevitz David F. Mammographic screening: no reliable supporting evidence? Lancet. 2002 Feb 2;359(9304):404–405. doi: 10.1016/S0140-6736(02)07592-X. [DOI] [PubMed] [Google Scholar]
  25. Mulshine J. L., Henschke C. I. Prospects for lung-cancer screening. Lancet. 2000 Feb 19;355(9204):592–593. doi: 10.1016/S0140-6736(99)00398-0. [DOI] [PubMed] [Google Scholar]
  26. Mulshine James L., Cuttitta Frank, Tockman Melvyn S., De Luca Luigi M. Lung cancer evolution to preinvasive management. Clin Chest Med. 2002 Mar;23(1):37–48. doi: 10.1016/s0272-5231(03)00058-3. [DOI] [PubMed] [Google Scholar]
  27. Nakamura H., Kawasaki N., Hagiwara M., Ogata A., Saito M., Konaka C., Kato H. Early hilar lung cancer--risk for multiple lung cancers and clinical outcome. Lung Cancer. 2001 Jul;33(1):51–57. doi: 10.1016/s0169-5002(00)00241-5. [DOI] [PubMed] [Google Scholar]
  28. Okamoto N., Suzuki T., Hasegawa H., Gotoh T., Hagiwara S., Sekimoto M., Kaneko M. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan. Lung Cancer. 1999 Aug;25(2):77–85. doi: 10.1016/s0169-5002(99)00046-x. [DOI] [PubMed] [Google Scholar]
  29. Olsen O., Gøtzsche P. C. Cochrane review on screening for breast cancer with mammography. Lancet. 2001 Oct 20;358(9290):1340–1342. doi: 10.1016/S0140-6736(01)06449-2. [DOI] [PubMed] [Google Scholar]
  30. Parkin D. M., Moss S. M. Lung cancer screening: improved survival but no reduction in deaths--the role of "overdiagnosis". Cancer. 2000 Dec 1;89(11 Suppl):2369–2376. doi: 10.1002/1097-0142(20001201)89:11+<2369::aid-cncr10>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  31. Peto R., Chen Z. M., Boreham J. Tobacco--the growing epidemic. Nat Med. 1999 Jan;5(1):15–17. doi: 10.1038/4691. [DOI] [PubMed] [Google Scholar]
  32. SLAUGHTER D. P., SOUTHWICK H. W., SMEJKAL W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953 Sep;6(5):963–968. doi: 10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  33. Shimatani H., Okunaka T., Shibuya H., Furukawa T., Ikeda N., Konaka C., Kato H. [Preoperative PDT for early stage lung cancer accompanied with infiltration to the central airway]. Kyobu Geka. 2001 Oct;54(11):957–961. [PubMed] [Google Scholar]
  34. Sobue T. [Epidemiology of lung cancer and prevention strategy in Japan]. Nihon Eiseigaku Zasshi. 1996 Oct;51(3):641–647. doi: 10.1265/jjh.51.641. [DOI] [PubMed] [Google Scholar]
  35. Strauss G., Dominioni L. Varese meeting report. Lung Cancer. 1999 Feb;23(2):171–172. doi: 10.1016/s0169-5002(99)00004-5. [DOI] [PubMed] [Google Scholar]
  36. Sutedja T. G., Venmans B. J., Smit E. F., Postmus P. E. Fluorescence bronchoscopy for early detection of lung cancer: a clinical perspective. Lung Cancer. 2001 Nov;34(2):157–168. doi: 10.1016/s0169-5002(01)00242-2. [DOI] [PubMed] [Google Scholar]
  37. Tabár L., Vitak B., Chen H. H., Yen M. F., Duffy S. W., Smith R. A. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001 May 1;91(9):1724–1731. doi: 10.1002/1097-0142(20010501)91:9<1724::aid-cncr1190>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  38. Tickle J. J., Sargent J. D., Dalton M. A., Beach M. L., Heatherton T. F. Favourite movie stars, their tobacco use in contemporary movies, and its association with adolescent smoking. Tob Control. 2001 Mar;10(1):16–22. doi: 10.1136/tc.10.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tockman M. S., Mulshine J. L., Piantadosi S., Erozan Y. S., Gupta P. K., Ruckdeschel J. C., Taylor P. R., Zhukov T., Zhou W. H., Qiao Y. L. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2237–2246. [PubMed] [Google Scholar]
  40. Wald N. Populist instead of professional. J Med Screen. 2000;7(1):1–1. doi: 10.1136/jms.7.1.1. [DOI] [PubMed] [Google Scholar]
  41. Wang D. L., Marko M., Dahl A. R., Engelke K. S., Placke M. E., Imondi A. R., Mulshine J. L., De Luca L. M. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. Clin Cancer Res. 2000 Sep;6(9):3636–3645. [PubMed] [Google Scholar]
  42. Wieder J. A., Belldegrun A. S. The utility of PSA doubling time to monitor prostate cancer recurrence. Mayo Clin Proc. 2001 Jun;76(6):571–572. doi: 10.4065/76.6.571. [DOI] [PubMed] [Google Scholar]
  43. Yankelevitz D. F., Reeves A. P., Kostis W. J., Zhao B., Henschke C. I. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology. 2000 Oct;217(1):251–256. doi: 10.1148/radiology.217.1.r00oc33251. [DOI] [PubMed] [Google Scholar]
  44. de Koning H. J. Assessment of nationwide cancer-screening programmes. Lancet. 2000 Jan 8;355(9198):80–81. doi: 10.1016/S0140-6736(99)00419-5. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES